Covid-19 Vaccines Must Be Based on Science, Not Speed: Johns Hopkins

The transcript discusses the availability of preliminary data from clinical trials and the importance of interpreting this data cautiously. It explains the FDA's role in vaccine approval, emphasizing the need for public trust and careful monitoring of vaccine safety. The discussion also covers the potential for fast-tracking vaccines, weighing the need for speed against ensuring safety and efficacy.

What are the potential consequences of fast-tracking vaccine approvals without sufficient data?

Why is it important to monitor vaccine trials carefully and not rush the approval process?